Literature DB >> 24839623

Exogenous and endogenous opioid-induced pain hypersensitivity in different rat strains.

Emilie Laboureyras, Frédéric Aubrun, Maud Monsaingeon, Jean-Benoît Corcuff, Jean-Paul Laulin, Guy Simonnet.   

Abstract

BACKGROUND: Opioid-induced hyperalgesia (OIH) is a recognized complication of opioid use that may facilitate the development of exaggerated postoperative pain.
OBJECTIVE: To examine the role of genetic factors on OIH by comparing four rat strains. Because the authors previously reported that the endogenous opioids released during non-nociceptive environmental stress induce latent pain sensitization, genetic and environmental factor interactions were also evaluated.
METHODS: First, the propensity of Sprague Dawley, Wistar, Lewis and Fischer rats to develop OIH following single or repeated fentanyl exposures was compared by measuring the nociceptive threshold using the paw pressure vocalization test. Second, Sprague Dawley and Fischer rats were exposed to a series of three non-nociceptive environmental stress sessions to evaluate the ability of endogenous opioids to enhance hyperalgesia associated with a carrageenan-induced hind-paw inflammation test performed two weeks later.
RESULTS: Sprague Dawley, Wistar and Lewis rats exhibited OIH, although differences were observed. OIH was not observed in Fischer rats. Inflammatory hyperalgesia enhancement induced through previous stress in Sprague Dawley rats was not observed in Fischer rats.
CONCLUSIONS: The pain level not only reflects nociceptive inputs but also depends on both the history and genetic factors of the individual. Genetic and environmental models may provide new insights into the mechanisms that underlie individual differences observed in postoperative pain.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24839623      PMCID: PMC4158934          DOI: 10.1155/2014/285308

Source DB:  PubMed          Journal:  Pain Res Manag        ISSN: 1203-6765            Impact factor:   3.037


  49 in total

1.  Evidence for opiate-activated NMDA processes masking opiate analgesia in rats.

Authors:  E Célèrier; J Laulin; A Larcher; M Le Moal; G Simonnet
Journal:  Brain Res       Date:  1999-11-13       Impact factor: 3.252

Review 2.  Allostasis, allostatic load, and the aging nervous system: role of excitatory amino acids and excitotoxicity.

Authors:  B S McEwen
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

3.  Genetic variants of the P-glycoprotein gene Abcb1b modulate opioid-induced hyperalgesia, tolerance and dependence.

Authors:  De-Yong Liang; Guochun Liao; Geoff K Lighthall; Gary Peltz; David J Clark
Journal:  Pharmacogenet Genomics       Date:  2006-11       Impact factor: 2.089

4.  Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance.

Authors:  T W Vanderah; L R Gardell; S E Burgess; M Ibrahim; A Dogrul; C M Zhong; E T Zhang; T P Malan; M H Ossipov; J Lai; F Porreca
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

5.  Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement.

Authors:  B Guignard; A E Bossard; C Coste; D I Sessler; C Lebrault; P Alfonsi; D Fletcher; M Chauvin
Journal:  Anesthesiology       Date:  2000-08       Impact factor: 7.892

6.  Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine.

Authors:  E Célèrier; C Rivat; Y Jun; J P Laulin; A Larcher; P Reynier; G Simonnet
Journal:  Anesthesiology       Date:  2000-02       Impact factor: 7.892

7.  Non-nociceptive environmental stress induces hyperalgesia, not analgesia, in pain and opioid-experienced rats.

Authors:  Cyril Rivat; Emilie Laboureyras; Jean-Paul Laulin; Chloé Le Roy; Philippe Richebé; Guy Simonnet
Journal:  Neuropsychopharmacology       Date:  2007-02-14       Impact factor: 7.853

8.  Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine.

Authors:  Vincent Joly; Philippe Richebe; Bruno Guignard; Dominique Fletcher; Pierre Maurette; Daniel I Sessler; Marcel Chauvin
Journal:  Anesthesiology       Date:  2005-07       Impact factor: 7.892

9.  Distinct mechanisms underlying pronociceptive effects of opioids.

Authors:  Céline Heinl; Ruth Drdla-Schutting; Dimitris N Xanthos; Jürgen Sandkühler
Journal:  J Neurosci       Date:  2011-11-16       Impact factor: 6.167

10.  Role of NK-1 neurotransmission in opioid-induced hyperalgesia.

Authors:  Tamara King; Luis R Gardell; Ruizhong Wang; Anna Vardanyan; Michael H Ossipov; Philip T Malan; Todd W Vanderah; Stephen P Hunt; Victor J Hruby; Josephine Lai; Frank Porreca
Journal:  Pain       Date:  2005-08       Impact factor: 7.926

View more
  5 in total

1.  Opioid Induced Hyperalgesia, a Research Phenomenon or a Clinical Reality? Results of a Canadian Survey.

Authors:  Grisell Vargas-Schaffer; Suzie Paquet; Andrée Neron; Jennifer Cogan
Journal:  J Pers Med       Date:  2020-04-21

2.  Discovery of Novel Proline-Based Neuropeptide FF Receptor Antagonists.

Authors:  Thuy Nguyen; Ann M Decker; Tiffany L Langston; Kelly M Mathews; Justin N Siemian; Jun-Xu Li; Danni L Harris; Scott P Runyon; Yanan Zhang
Journal:  ACS Chem Neurosci       Date:  2017-08-09       Impact factor: 4.418

3.  Neurobiological Effects of Morphine after Spinal Cord Injury.

Authors:  Michelle A Hook; Sarah A Woller; Eric Bancroft; Miriam Aceves; Mary Katherine Funk; John Hartman; Sandra M Garraway
Journal:  J Neurotrauma       Date:  2016-11-02       Impact factor: 5.269

4.  In Vitro Nociceptor Neuroplasticity Associated with In Vivo Opioid-Induced Hyperalgesia.

Authors:  Eugen V Khomula; Dioneia Araldi; Jon D Levine
Journal:  J Neurosci       Date:  2019-07-12       Impact factor: 6.167

5.  Mu Opioid Splice Variant MOR-1K Contributes to the Development of Opioid-Induced Hyperalgesia.

Authors:  Folabomi A Oladosu; Matthew S Conrad; Sandra C O'Buckley; Naim U Rashid; Gary D Slade; Andrea G Nackley
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.